The function of invariant chain in class ii-restricted antigen presentation

Seminars in Immunology

Volumn 7, Issue 6, 1995, Pages 373-387

  Ceman, Stephanie ^a   Sant, Andrea J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antigen presentation; Class II; Invariant chain; Major histocompatibility complex

Indexed keywords

B LYMPHOCYTE ANTIGEN; CHAPERONE; EPITOPE; HLA ANTIGEN CLASS 2; PEPTIDE;

ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; BIOSYNTHESIS; ENDOPLASMIC RETICULUM; ENDOSOME; HUMAN; IMMUNOLOGY; INVARIANT CHAIN; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FOLDING; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ENDOPLASMIC RETICULUM; ENDOSOMES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR CHAPERONES; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING;

EID: 0029439973     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1995.0042     Document Type: Article

References (88)

1. Jones PP, Murphy DB, Hewgill D, McDevitt HO (1978) Detection of a common polypeptide chain in I-A and I-E subregion immunoprecipitates. Immunochemistry 16:51-60
2. Yamamoto K, Floyd-Smith G, Francke U, Koch N, Lauer W, Dobberstein B, Schafer R, Hammerling GJ (1985) The gene encoding the Ia-associated invariant chain is located on chromosome 18 in the mouse. Immunogenetics 21:83-90
3. Genuardi M, Saunders GF (1988) Localization of the HLA class II-associated invariant chain gene to human chromosome band 5q32. Immunogenetics 28:53-56
4. Eades A-M, Litfin M, Rahmsdorf HJ (1990) The IFN-gamma response of the murine invariant chain gene is mediated by a complex enhancer that includes several MHC class II consensus elements. J Immunol 144:4399-4409
5. Brown AM, Barr CL, Ting JP (1991) Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene. J Immunol 146:3183-3189
6. Benoist C, Mathis D (1990) Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8:681-715
7. Glimcher LH, Kara CJ (1992) Sequences and factors: A guide to MHC class-II transcription. Annu Rev Immunol 10:13-49
8. O’Sullivan DM, Noonan D, Quaranta V (1987) Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J Exp Med 166:444-460
9. Strubin M, Berte C, Mach B (1986) Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO 5:3483-3488
10. Koch N, Lauer W, Habicht J, Dobberstein B (1987) Primary structure of the gene for the murine Ia antigen-associated invariant chain (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO 6:1677-1683
11. Sant AJ, Schwartz BD, Cullen SE (1985) Cellular distribution of the Ia-associated chondroitin sulfate proteoglycan. J Immunol 135:408-415
12. Bakke O, Dobberstein B (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707-716
13. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Petersen PA (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600-605
14. Roche PA, Marks MS, Cresswell P (1991) Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392-394
15. Anderson KS, Cresswell P (1994) A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO 13:675-682
16. Lamb CA, Cresswell P (1992) Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunology 148:3478-3482
17. Peters PJ, Neefjes JJ, Oorschot U, Ploegh H, Geuze HJ (1991) Segregation of MHC class II molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669-676
18. Lamb CA, Yewdell JW, Bennink JR, Cresswell P (1991) Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl Acad Sci USA 88:5998-6002
19. Roche PA, Teletski CL, Stang E, Bakke O, Long EO (1993) Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 90:8581-8585
20. Blum JS, Cresswell P (1988) Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85:3975-3979
21. Maric MA, Taylor MD, Blum JS (1994) Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci USA 91:2171-2175
22. Nguyen QV, Humphreys RE (1989) Time course of intracellular associations, processing, and cleavages of Ii forms and class II major histocompatibility complex molecules. J Cell Biol 264:1631-1647
23. Sekaly JP, Jacobsen S, Richert JR, Tonnelle C, McFarland HF, Long EO (1988) Antigen presentation to HLA class II-restricted measles virus-specific T cell clones can occur in the absence of the invariant chain. Proc Natl Acad Sci USA 85:1209-1212
24. Stockinger B, Pessara U, Lin RH, Habicht J, Grez M, Koch N (1989) A role of Ia-associated invariant chains in antigen processing and presentation. Cell 56:683-689
25. Nadimi F, Moreno J, Momburg F, Heuser A, Fuchs S, Adorini L, Hammerling G (1991) Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur J Immunol 21:1255-1263
26. Peterson M, Miller J (1992) Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596-598
27. Lombard-Platet S, Bertolino P, Gimenez C, Humbert M, Gerlier D, Rabourdin-Combe C (1993) Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules. Cellular Immunology 148:60-70
28. Bertolino P, Forquet F, Pont S, Koch N, Gerlier D, Rabourdin-Combe C (1991) Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells. Int Immunol 3:435-443
29. Momburg F, Fuchs S, Drexler J, Busch R, Post M, Hammerling GJ, Adorini L (1993) Epitope-specific enhancement of antigen presentation by invariant chain. J Exp Med 178:1453-1458
30. Humbert M, Bertolino P, Forquet F, Rabourdin-Combe C, Gerlier D, Davoust J, Salamero J (1993) Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Eur J Immunol 23:3167-3172
31. Anderson MS, Swier K, Arneson L, Miller J (1993) Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J Exp Med 178:1959-1969
32. Dodi AI, Brett S, Nordeng T, Sidhu S, Batchelor RJ, Lombardi G, Bakke O, Lechler RI (1994) The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur J Immunol 24:1632-1639
33. Pinet V, Malnati M, Long EO (1994) Two processing pathways for the MHC class II restricted presentation of exogenous influenza virus antigen. J Immunol 4852-4860
34. Long EO, LaVaute T, Pinet V, Jaraquemada D (1994) Invariant chain prevents the HLA-DR restricted presentation of a cytosolic peptide. J Immunol 1487-1494
35. Nijenhuis M, Calafat J, Kuijpers KC, Janssen H, de Haas M, Nordeng TW, Bakke O, Neefjes JJ (1994) Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling. Eur J Immunol 24:873-883
36. Bikoff EK, Huang Y, Episkopou V, van Meerwijk J, Germain RJ, Robertson EJ (1993) Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4 + T cell selection in mice lacking invariant chain expression. J Exp Med 177:1699-1712
37. Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA (1994) The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 179:681-694
38. Bodmer H, Viville S, Benoist C, Mathis D (1994) Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284-1286
39. Stebbins C, Loss GE Jr., Elias CG, Chervonsky AV, Sant AJ (1994) The requirement for DM in Class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J Exp Med 181:223-234
40. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D (1993) Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648
41. Dornmair K, McConnell HM (1990) Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide binding. Proc Natl Acad Sci USA 87:4134-4138
42. Dornmair K, Rothenhausler B, McConnell HM (1989) Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp Quantit Biol 54:409-416
43. Bikoff EK, Germain RN, Robertson EJ (1995) Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301-310
44. Teyton L, O’Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Petersen PA (1990) Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39-44
45. Bijlmakers M-JJE, Benaroch P, Ploegh H (1994) Assembly of HLA DR1 molecules translated in vitro: Binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO 13:2699-2707
46. Peterson M, Miller J (1990) Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172-174
47. Miller J, Germain R (1986) Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med 164:1478-1489
48. Sekaly R, Tonnelle C, Strubin M, Mach B, Long EO (1986) Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med 164:1490-1504
49. Simonis S, Miller J, Cullen S (1989) The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins. J Immunol 143:3619-3625
50. Layet C, Germain RN (1991) Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II MHC alpha beta dimers from the ER/cis-Golgi compartment. Proc Natl Acad Sci USA 88:2346-2350
51. Schaiff WT, Hruska KA, Bono C, Shuman S, Schwartz BD (1991) Invariant chain influences post-translational processing of HLA-DR molecules. J Immunol 147:603-608
52. Anderson MS, Miller J (1992) Invariant chain can function as a chaperone protein for class II MHC molecules. Proc Natl Acad Sci USA 89:2282-2286
53. Sant AJ, Cullen SE, Schwartz BD (1985) Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins. J Immunol 135:421-422
54. Miller J, Hatch JA, Simonis S, Cullen SE (1988) Identification of the glycoaminoglycan-attachment site of mouse invariant chain proteoglycan core protein by site-directed mutagenesis. Proc Natl Acad Sci USA 85:1359-1363
55. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J (1993) The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:1-20
56. Roche PA, Teletski CL, Karp DR, Bakke O, Long EO (1992) Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO 11:2841-2847
57. Roche PA, Cresswell P (1990) Invariant chain association with HLR-DR molecules inhibits immunogenic peptide binding. Nature 345:615-618
58. Swier K, Miller J (1995) Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation. J Immunol 155:630-643
59. Newcomb JR, Cresswell P (1993) Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J Immunol 151:4153-4163
60. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474-477
61. Chervonsky AV, Gordon L, Sant AJ (1994) A lumenal sequence in the class II MHC beta chain controls targeting of class II molecules to the endocytic pathway. Int Immunol 6:973-982
62. Qui Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK (1994) Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol 125:595-605
63. Amigorena S, Drake JR, Webster P, Mellman I (1994) Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113-120
64. West MA, Lucocq JM, Watts C (1994) Antigen processing and class II MHC peptide-loading compartments in human B-lym-phoblastoid cells. Nature 369:147-150
65. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J (1994) Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120-126
66. Castellino F, Germain RN (1995) Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73-88
67. Rudensky AY, Maric M, Eastman S, Shoemaker L, DeRoos PC, Blum JS (1994) Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1:585-594
68. Neefjes JJ, Ploegh HL (1992) Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant alpha beta heterodimers in endosomes. EMBO 11:411-416
69. Cresswell P (1985) Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. Proc Natl Acad Sci USA 82:8188-8192
70. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL (1990) The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171-183
71. Loss GE, Sant AJ (1993) Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 150:3187-3197
72. Gorvel J-P, Escola J-M, Stang E, Bakke O (1995) Invariant chain induces a delayed transport from early to late endosomes. J Biol Chem 270:2741-2746
73. Romagnoli P, Layet C, Yewdell J, Bakke O, Germain R (1993) Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 177:583-596
74. Ogrinc T, Dolenc I, Ritonja A, Turk V (1993) Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett 336:555-559
75. Katunuma N, Hisao K, Matsunaga Y, Saibara T (1994) Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family. FEBS Lett 349:265-269
76. Sette A, Southwood S, Miller J, Appella E (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med 181:677-683
77. Malcherek G, Gnau V, Jung G, Rammensee HG, Melms A (1995) Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med 181:527-536
78. Sette A, Ceman S, Kubo RT, Sakaguchi K, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R, Grey HM, DeMars R (1992) Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801-1804
79. Ghosh P, Amaya M, Mellins E, Wiley DC (1995) The structure of an intermediate in class II MHC maturation, HLA-DR3 complexed with the invariant chain fragment CLIP. Nature, in press
80. Tampe R, McConnell HM (1991) Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad. Proc Natl Acad Sci USA 88:4661-4665
81. Pedrazzini T, Sette A, Albertson M, Grey HM (1991) Free ligand-induced dissociation of MHC-antigen complexes. J Immunol 146:3496-3501
82. Sadegh-Nasseri S, McConnell HM (1989) A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature 337:274-276
83. Sadegh-Nasseri S, Germain RN (1991) A role for peptide in determining MHC class II structure. Nature 353:167-170
84. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-806
85. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha-beta dimers and facilitates peptide loading. Cell 82:155-165
86. Fineschi B, Arneson LS, Naujokas MF, Miller J (1995) Proteolysis of MHC class II-associated invariant chain is regulated by the alternatively spliced, p41, gene product. Proc Natl Acad Sci USA in press
87. Kampgen E, Koch N, Koch F, Stoger P, Heufler C, Schuler G, Romani N (1991) Class II major histocompatibility complex molecules of murine dendritic cells: Synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA 88:3014-3018
88. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL (1993) Specificity and promiscuity among naturally processed peptides bond to HLA-DR alleles. J Exp Med 178:27-47